Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
Malignant gliomas have a highly tumorigenic subpopulation, termed cancer stem cells (CSCs), that drives tumor formation and proliferation. CSCs possess inherent resistance mechanisms against radiation- and chemotherapy- induced cancer cell death, enabling them to survive and initiate tumor recurrenc...
| Main Authors: | Warrier, S., Balu, S., Kumar, Alan Prem, Michael, M., Dharmarajan, Arunasalam |
|---|---|
| Format: | Journal Article |
| Published: |
Cognizant Communication Corporation
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/20326 |
Similar Items
The Role of Secreted Frizzled Related Protein 4 (sFRP-4) in Regulating Oestradiol-Induced Growth of the MCF-7 Breast Cancer Cell Line
by: McLaren, S., et al.
Published: (2014)
by: McLaren, S., et al.
Published: (2014)
Expression Profile of Wnt/β-Catenin Signalling Molecules and the Wnt Antagonist Secreted Frizzled-Related Protein 4 in Apoptosis in Breast Cancer Tissue Micro-Arrays
by: Berry, A., et al.
Published: (2014)
by: Berry, A., et al.
Published: (2014)
The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro
by: Longman, D., et al.
Published: (2012)
by: Longman, D., et al.
Published: (2012)
Secreted Frizzled-Related Protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers
by: Saran, U., et al.
Published: (2012)
by: Saran, U., et al.
Published: (2012)
The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
Wnt antagonist, secreted frizzled-related protein 4 (SFRP4) and peptides from its associated domains, increases chemotherapeutic response of cancer stem cells of malignant mesothelioma cell lines
by: Perumal, V., et al.
Published: (2017)
by: Perumal, V., et al.
Published: (2017)
Discovery of AZD-2098 and AZD-1678, two potent and bioavailable CCR4 receptor antagonists
by: Kindon, Nicholas, et al.
Published: (2017)
by: Kindon, Nicholas, et al.
Published: (2017)
Regulation of cancer stem cell metabolism by secreted frizzled-related protein 4 (SFRP4)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)
by: Fox, Simon, et al.
Published: (2013)
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
by: Bhuvanalakshmi, G., et al.
Published: (2019)
by: Bhuvanalakshmi, G., et al.
Published: (2019)
Secreted Frizzled related protein-4 (sFRP4) promotes epidermal differentiation and apoptosis
by: Maganga, R., et al.
Published: (2008)
by: Maganga, R., et al.
Published: (2008)
The roles of WNT1 and DKK1 during in vitro neural differentiation of mouse embryonic stem cell lines
by: Gao, Liyang
Published: (2013)
by: Gao, Liyang
Published: (2013)
Visual and neuropsychological outcomes following paediatric optic pathway glioma
by: Papini, Chiara
Published: (2020)
by: Papini, Chiara
Published: (2020)
The role of miRNA regulation in response to hypoxia in
gliomas
by: Smith, Louise
Published: (2023)
by: Smith, Louise
Published: (2023)
The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain
by: Perumal, Vanathi, et al.
Published: (2017)
by: Perumal, Vanathi, et al.
Published: (2017)
SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)
by: Warrier, Sudha, et al.
Published: (2016)
Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt ß-catenin signaling via the Wnt antagonist secreted frizzled related protein-4
by: Bhuvanalakshmi, G., et al.
Published: (2017)
by: Bhuvanalakshmi, G., et al.
Published: (2017)
Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines
by: Ivanov, D.P., et al.
Published: (2016)
by: Ivanov, D.P., et al.
Published: (2016)
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties
by: Bhuvanalakshmi, G., et al.
Published: (2015)
by: Bhuvanalakshmi, G., et al.
Published: (2015)
Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines
by: Deshmukh, A., et al.
Published: (2017)
by: Deshmukh, A., et al.
Published: (2017)
SFRP-4 abrogates Wnt-3a-induced ß-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation
by: Constantinou, T., et al.
Published: (2008)
by: Constantinou, T., et al.
Published: (2008)
Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domain
by: Agostino, M., et al.
Published: (2017)
by: Agostino, M., et al.
Published: (2017)
Long-term exposure to irinotecan reduces cell migration in glioma cells.
by: Al-Ghafari, Ayat B., et al.
Published: (2016)
by: Al-Ghafari, Ayat B., et al.
Published: (2016)
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
by: Warrier, Sudha, et al.
Published: (2014)
by: Warrier, Sudha, et al.
Published: (2014)
The information and support needs of patients diagnosed with High Grade Glioma
by: Halkett, Georgia, et al.
Published: (2009)
by: Halkett, Georgia, et al.
Published: (2009)
Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
by: Yu, X., et al.
Published: (2014)
by: Yu, X., et al.
Published: (2014)
Wnt antagonist secreted frizzled-related protein 4 upregulates adipogenic differentiation in human adipose tissue-derived mesenchymal stem cells
by: Visweswaran, Malini, et al.
Published: (2015)
by: Visweswaran, Malini, et al.
Published: (2015)
Epigenetic demthylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
by: Deshmukh, A., et al.
Published: (2019)
by: Deshmukh, A., et al.
Published: (2019)
Predictors of distress and poorer quality of life in High Grade Glioma patients
by: Halkett, Georgia, et al.
Published: (2015)
by: Halkett, Georgia, et al.
Published: (2015)
Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control to diabetes mellitus
by: Bukhari, Shazia Anwer, et al.
Published: (2014)
by: Bukhari, Shazia Anwer, et al.
Published: (2014)
Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a
by: Perumal, V., et al.
Published: (2015)
by: Perumal, V., et al.
Published: (2015)
The Role of Secreted Frizzled-related Protein-4 (sFRP4) in the Epigenetics, Metabolism and Chemo-sensitisation of Cancer Stem Cells
by: Deshmukh, Abhijeet Popatrao
Published: (2017)
by: Deshmukh, Abhijeet Popatrao
Published: (2017)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma: a final report
by: Gnekow, Astrid K., et al.
Published: (2017)
by: Gnekow, Astrid K., et al.
Published: (2017)
Swap70b is required for convergent and extension cell movement during zebrafish gastrulation linking Wnt11 signalling and RhoA effector function
by: Xu, Xiaoou, et al.
Published: (2014)
by: Xu, Xiaoou, et al.
Published: (2014)
FLYWCH1, a novel transcription regulator with potential tumour suppressor activity
by: Almozyan, Sheema
Published: (2021)
by: Almozyan, Sheema
Published: (2021)
Secreted frizzled-related protein 4 and its implications in cancer and apoptosis
by: Pohl, S., et al.
Published: (2015)
by: Pohl, S., et al.
Published: (2015)
Secreted frizzled-related protein 4: An angiogenesis inhibitor
by: Muley, A., et al.
Published: (2010)
by: Muley, A., et al.
Published: (2010)
Characterisation of the deubiquitinating enzyme USP4
by: Indrayudha, Peni
Published: (2018)
by: Indrayudha, Peni
Published: (2018)
Structural changes in the anterior visual pathway and its correlation with functional visual outcome: a case-control study of children with optic pathway gliomas
by: Higgins, Bethany E.
Published: (2018)
by: Higgins, Bethany E.
Published: (2018)
Characterisation of glioblastoma sub-populations using mathematical modelling and inference
by: Morris, Bethan Edith
Published: (2022)
by: Morris, Bethan Edith
Published: (2022)
Similar Items
-
The Role of Secreted Frizzled Related Protein 4 (sFRP-4) in Regulating Oestradiol-Induced Growth of the MCF-7 Breast Cancer Cell Line
by: McLaren, S., et al.
Published: (2014) -
Expression Profile of Wnt/β-Catenin Signalling Molecules and the Wnt Antagonist Secreted Frizzled-Related Protein 4 in Apoptosis in Breast Cancer Tissue Micro-Arrays
by: Berry, A., et al.
Published: (2014) -
The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro
by: Longman, D., et al.
Published: (2012) -
Secreted Frizzled-Related Protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers
by: Saran, U., et al.
Published: (2012) -
The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)